Innogene Kalbiotech

Innogene Kalbiotech

Singapore - Singapore
Diagnostics

Focus: Biologics, Biosimilars, Diagnostics

Innogene Kalbiotech is a life sciences company focused on Biologics, Biosimilars, Diagnostics.

OncologyCardiovascularInfectious Diseases
Funding Stage
PUBLIC
Open Jobs
0

Pipeline & Clinical Trials

0.5M Sodium lactate
Acute Heart Failure
Phase 2
Clinical Trials (1)
NCT019816550.5M Na Lactate Solution in Acute Heart Failure (AHF)
Phase 2
Phase 2
Clinical Trials (1)
NCT00702481Study of Nimotuzumab and Cisplatin/Radiotherapy for Locally Advanced Head and Neck Squamous Cell Cancer
Phase 2
Clinical Trials (1)
NCT00957086Study of Post-Op Adjuvant Concurrent Chemo-RT With or Without Nimotuzumab for Head & Neck Cancer
Phase 3
Racotumomab
NSCLC
Phase 3
Clinical Trials (1)
NCT01460472Immunotherapy With Racotumomab in Advanced Lung Cancer
Phase 3
Hypertonic lactate
Low Cardiac Output
Phase 3
Clinical Trials (1)
NCT00529490Efficacy, Safety of Hypertonic Lactate Soln. as Fluid Resuscitation Compared With Ringer's Lactate in Post-CABG Pats
Phase 3
Hyperosmolar sodium lactate
Hemorrhagic Shock
Phase 3
Clinical Trials (1)
NCT01433276Efficacy, Safety of Solution Containing Hyperosmolar Sodium Lactate Infusion for Resuscitation of Patients With Hemorrhagic Shock
Phase 3
Hypertonic lactate
Low Cardiac Output
Phase 3
Clinical Trials (1)
NCT00529711The Efficacy of Hypertonic Lactate Solution in CABG(Coronary Artery Bypass Grafting) Patients
Phase 3
Hypertonic sodium lactate
Dengue Shock Syndrome
Phase 3
Clinical Trials (1)
NCT00966628Effect of Hypertonic Sodium Lactate on sVCAM-1 Level as Surrogate Marker of Endothelial Capillary Leakage in Pediatric Dengue Shock Syndrome Patients (DSS)
Phase 3
Hypertonic sodium lactate
Coronary Heart Disease
Phase 4
Clinical Trials (1)
NCT01654653Efficacy and Safety of Hypertonic Sodium Lactate Solution Compared With 6% HES Solution in CABG Patients
Phase 4

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts
Founded: 2003
Portfolio: 9 clinical trials